Differential expression of vitamin D-associated enzymes and receptors in brain cell subtypes
暂无分享,去创建一个
D. Eyles | F. Féron | D. Stephan | V. Landel | X. Cui
[1] C. Annweiler,et al. Vitamin D, Cognition and Alzheimer’s Disease: The Therapeutic Benefit is in the D-Tails , 2016, Journal of Alzheimer's disease : JAD.
[2] Mandy Boontanrart,et al. Vitamin D3 alters microglia immune activation by an IL-10 dependent SOCS3 mechanism , 2016, Journal of Neuroimmunology.
[3] B. Loriod,et al. Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer’s disease , 2016, Molecular Neurodegeneration.
[4] J. Honnorat,et al. Inhibitory axons are targeted in hippocampal cell culture by anti-Caspr2 autoantibodies associated with limbic encephalitis , 2015, Front. Cell. Neurosci..
[5] Helen Gooch,et al. Vitamin D and the brain: Key questions for future research , 2015, The Journal of Steroid Biochemistry and Molecular Biology.
[6] D. Wion,et al. Expression of CYP2R1 and VDR in human brain pericytes: the neurovascular vitamin D autocrine/paracrine model , 2015, Neuroreport.
[7] N. Garbi,et al. The 1,25D3‐MARRS receptor/PDIA3/ERp57 and lifespan , 2015, Journal of cellular biochemistry.
[8] M. Khrestchatisky,et al. Setting-up an In Vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport , 2014, Journal of visualized experiments : JoVE.
[9] P. Liu,et al. Intracellular distribution of the vitamin D receptor in the brain: Comparison with classic target tissues and redistribution with development , 2014, Neuroscience.
[10] Y. Goto,et al. Diosgenin-induced cognitive enhancement in normal mice is mediated by 1,25D3-MARRS , 2013, Scientific Reports.
[11] B. Boyan,et al. Plasma membrane Pdia3 and VDR interact to elicit rapid responses to 1α,25(OH)(2)D(3). , 2013, Cellular signalling.
[12] S. Yılmazer,et al. Vitamin D inquiry in hippocampal neurons: consequences of vitamin D-VDR pathway disruption on calcium channel and the vitamin D requirement , 2013, Neurological Sciences.
[13] M. Khrestchatisky,et al. Cholecalciferol (Vitamin D3) Improves Myelination and Recovery after Nerve Injury , 2013, PloS one.
[14] E. Hol,et al. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue. , 2013, Journal of neuropathology and experimental neurology.
[15] B. Boyan,et al. Mechanism of Pdia3-dependent 1α,25-dihydroxy vitamin D3 signaling in musculoskeletal cells , 2012, Steroids.
[16] I. Nemere,et al. Diosgenin is an exogenous activator of 1,25D3-MARRS/Pdia3/ERp57 and improves Alzheimer's disease pathologies in 5XFAD mice , 2012, Scientific Reports.
[17] M. Khrestchatisky,et al. Severity of experimental autoimmune encephalomyelitis is unexpectedly reduced in mice born to vitamin D-deficient mothers , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[18] J. Pike,et al. A Downstream Intergenic Cluster of Regulatory Enhancers Contributes to the Induction of CYP24A1 Expression by 1α,25-Dihydroxyvitamin D3* , 2010, The Journal of Biological Chemistry.
[19] Jie Peng,et al. Isolation and culture of rat and mouse oligodendrocyte precursor cells , 2007, Nature Protocols.
[20] I. Nemere,et al. The ERp57/GRp58/1,25D3-MARRS receptor: multiple functional roles in diverse cell systems. , 2007, Current medicinal chemistry.
[21] A. Mackay-Sim,et al. Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[22] S. Rivera,et al. Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study , 2005, BMC Neuroscience.
[23] J. McGrath,et al. Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain , 2005, Journal of Chemical Neuroanatomy.
[24] H. DeLuca,et al. Vitamin D Receptor , 2002 .
[25] P. Brachet,et al. Rat oligodendrocytes express the vitamin D3 receptor and respond to 1,25‐dihydroxyvitamin D3 , 2000, Glia.
[26] W. Miller,et al. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. , 1997, Molecular endocrinology.
[27] P. Brachet,et al. Expression of 25(OH) vitamin D3 24-hydroxylase gene in glial cells. , 1993, Neuroreport.
[28] W. Pardridge,et al. Restricted Transport of Vitamin D and A Derivatives Through the Rat Blood‐Brain Barrier , 1985, Journal of neurochemistry.
[29] H. Pols,et al. Vitamin D , 1928, Calcified Tissue International.
[30] Steven A. Smith,et al. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. , 2005, Journal of chemical neuroanatomy.